HYCAMTIN 0.25 mg (Hycamtin 0.25 mg)
Generic Name: topotecan
Pill imprint HYCAMTIN 0.25 mg has been identified as Hycamtin 0.25 mg.
Hycamtin is used in the treatment of ovarian cancer; small cell lung cancer; cervical cancer; cancer and belongs to the drug class miscellaneous antineoplastics. There is positive evidence of human fetal risk during pregnancy. Hycamtin 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- topotecan
- Imprint:
- HYCAMTIN 0.25 mg
- Strength:
- 0.25 mg
- Color:
- White
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antineoplastics
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00007-4205
- Inactive Ingredients:
- glyceryl monostearate
gelatin
titanium dioxide
More about Hycamtin (topotecan)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
